208 related articles for article (PubMed ID: 27594784)
21. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
[TBL] [Abstract][Full Text] [Related]
22. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
[TBL] [Abstract][Full Text] [Related]
23. Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP
Du Preez S; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831634
[TBL] [Abstract][Full Text] [Related]
24. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
[TBL] [Abstract][Full Text] [Related]
25. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
Front Immunol; 2020; 11():582330. PubMed ID: 33329554
[TBL] [Abstract][Full Text] [Related]
26. Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Maya J
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569313
[TBL] [Abstract][Full Text] [Related]
27. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
J Transl Med; 2015 Sep; 13():299. PubMed ID: 26370228
[TBL] [Abstract][Full Text] [Related]
29. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D
J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
[TBL] [Abstract][Full Text] [Related]
30. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Rivas JL; Palencia T; Fernández G; García M
Front Immunol; 2018; 9():1028. PubMed ID: 29867995
[TBL] [Abstract][Full Text] [Related]
31. Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Jeremijenko A; Griffin P; Marshall-Gradisnik S
Front Immunol; 2024; 15():1264702. PubMed ID: 38765011
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; Ashton KJ; van Driel M; Staines DR; Peterson D; Atkinson GM; Marshall-Gradisnik SM
J Affect Disord; 2012 Dec; 141(2-3):261-9. PubMed ID: 22572093
[TBL] [Abstract][Full Text] [Related]
34. Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Theorell J; Bileviciute-Ljungar I; Tesi B; Schlums H; Johnsgaard MS; Asadi-Azarbaijani B; Bolle Strand E; Bryceson YT
Front Immunol; 2017; 8():723. PubMed ID: 28694809
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
[TBL] [Abstract][Full Text] [Related]
36. Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
Int J Med Sci; 2015; 12(10):764-72. PubMed ID: 26516304
[TBL] [Abstract][Full Text] [Related]
37. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
[TBL] [Abstract][Full Text] [Related]
38. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
[TBL] [Abstract][Full Text] [Related]
39. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.
Wirth K; Scheibenbogen C
Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M; Twisk FN; Ringel K
Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
